Anxiety disorders are among the most prevalent, persistent,
disabling, and costly psychiatric disorders, yet they are often
underdiagnosed and undertreated. Fortunately, there have been major
advances in understanding and treating these conditions in recent
years; this is one of the most exciting areas in modern medicine.
This clinical manual has earned its place in the literature as
one of just a few volumes that covers all of the major anxiety
disorders and presents integrated contributions from both
psychopharmacologists and psychotherapists& mdash;all in one
compact work written for busy clinicians.
Though concepts of anxiety have long enjoyed a central position
in philosophical and psychoanalytic theories, empirical research on
anxiety disorders has a relatively short history. Here, 16 experts
discuss advances in diagnosis, assessment (including relevant
rating scales), pharmacotherapy, and psychotherapy.
This volume begins by reviewing recent important diagnostic,
epidemiological, neurobiological, and treatment findings&
mdash;all of which have significant implications for clinicians.
Subsequent chapters cover "Panic disorder and agoraphobia"&
mdash;Laboratory studies of fear have significantly advanced our
understanding of the neurocircuitry and neurochemistry of panic.
Furthermore, panic disorder is now readily treated with both
medications and psychotherapy.
"Specific phobia"& mdash;Viewed for many years as mild and
even trivial, this common disorder is now recognized for its very
real associated distress and impairment. Exposure therapy is the
treatment mainstay, though pharmacotherapy should be considered
particularly when there is comorbidity.
"Social phobia"(or social anxiety disorder)& mdash;In the
past few years, the first FDA-approved medications for this
disorder have been made available. Cognitive-behavioral therapy is
also effective for the treatment of this underdiagnosed and
"Obsessive-compulsive disorder (OCD)"& mdash;OCD was the
first disorder where it was shown that both specific medications
and cognitive-behavioral techniques resulted in normalization of
activity in particular brain structures. It is now possible to
provide patients with integrated treatment approaches.
"Posttraumatic stress disorder (PTSD)"& mdash;Once viewed as
a normal reaction to trauma, PTSD is increasingly understood as a
pathological response, characterized by specific psychobiological
dysfunctions. Again, there have been exciting advances in the
treatment of this disorder, with the release of the first
FDA-approved agents for PTSD.
"Generalized anxiety disorder (GAD)"& mdash;For a number of
years GAD was thought of as a residual disorder occasionally seen
in combination with more primary conditions. Nowadays, we know that
GAD is an independent condition that is prevalent, persistent, and
Busy residents and psychiatrists in active clinical practice,
psychologists, primary care practitioners, and other mental health
professionals will find this clinical manual& mdash;with its
integrated approach of both pharmacotherapy and psychotherapy&
mdash;a valuable tool in their everyday practices.
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!